@article{ed749007d2c34da2afe7cd2430283582,
title = "The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer",
abstract = "N/A",
keywords = "Boost, Chemoradiation, Oxaliplatin, Pathologic complete response, Preoperative radiochemotherapy, Rectal cancer, Boost, Chemoradiation, Oxaliplatin, Pathologic complete response, Preoperative radiochemotherapy, Rectal cancer",
author = "Vincenzo Valentini and Gambacorta, {Maria Antonietta} and Claudio Coco and Brunella Barbaro and Sergio Alfieri and Domenico D'Ugo and Roberto Persiani and Francesco Deodato and Antonio Crucitti and Francesco Cellini and Barba, {Maria Cristina} and Vecchio, {Fabio Maria} and Morganti, {Alessio Giuseppe} and {La Torre}, Giuseppe and Marco Lupattelli and Federico Navarria and Claudio Belluco and Angela Buonadonna and Caterina Boso and Sara Lonardi and Luciana Caravatta and Ernesto Maranzano and Salvatore Pucciarelli and {De Paoli}, Antonio",
year = "2019",
doi = "10.1016/j.radonc.2018.11.023",
language = "English",
volume = "134",
pages = "110--118",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Science Ireland Limited:PO Box 85, Limerick Ireland:011 353 61 709600, 011 353 61 61944, EMAIL: usinfo-f@elsevier.com, INTERNET: http://www.elsevier.com, Fax: 011 353 61 709114",
}